17:20 EST Amneal Pharmaceuticals (AMRX) to replace TTM Technologies (TTMI) in S&P 600 at open on 1/30
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMRX:
- Amneal Pharmaceuticals Files Routine Regulation FD Disclosure Report
- Amneal Pharmaceuticals, KeifeRx enter research collaboration, option agreement
- Amneal Pharmaceuticals price target raised to $15 from $14 at Truist
- Amneal Pharmaceuticals announces FDA approval for Boncresa, Oziltus BLAs
- Amneal Pharmaceuticals announces FDA approval for epinephrine injection vials